Pancreatic cancer surgery

Revision as of 19:45, 19 December 2011 by Kristin Feeney (talk | contribs)
Jump to navigation Jump to search

Pancreatic cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pancreatic Cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pancreatic cancer surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pancreatic cancer surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pancreatic cancer surgery

CDC on Pancreatic cancer surgery

Pancreatic cancer surgery in the news

Blogs on Pancreatic cancer surgery

Directions to Hospitals Treating Pancreatic cancer

Risk calculators and risk factors for Pancreatic cancer surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Overview

The selection of a treatment intervention depends largely on the disease progression and the patient's stage of cancer. The most common surgical treatment for cancer involving the pancreas is the Whipple procedure.

Surgical Therapy

Treatment of pancreatic cancer depends on the stage of the cancer.[1] The Whipple procedure is the most common surgical treatment for cancers involving the head of the pancreas. It can only be performed if the patient is likely to survive major surgery and if the cancer is localised without invading local structures or metastasizing. It can therefore only be performed in the minority of cases.

Spleen-preserving distal pancreatectomy can also be used as a method to remove a cancer running through centre of pancreas; this is invasive surgery, resulting in loss of body and tail. Cancers of the tail of the pancreas can be resected using a procedure known as a distal pancreatectomy.[2] Recently, localized cancers of the pancreas have been resected using minimally invasive (laparoscopic) approaches.

After surgery, adjuvant chemotherapy with gemcitabine may be offered to eliminate whatever cancerous tissue may remain in the body. This has been shown to increase 5-year survival rates. Addition of radiation therapy is a hotly debated topic, with groups in the US often favoring the use of adjuvant radiation therapy, while groups in Europe do not.[3]

Surgery can be performed for palliation, if the malignancy is invading or compressing the duodenum or colon. In that case, bypass surgery might overcome the obstruction and improve quality of life, but it is not intended as a cure.

Criteria for Unresectability:

  • Tumor larger than 5 cm
  • Tumor invades adjacent tissue of organs (excluding duodenum)
  • Encasement, stenosis, or occlusion of the celiac artery, celiac artery branches, and/or SMA.
  • PV and/or SMV encasement (some centers will operate with venous invasion)
  • Hepatic metastases
  • Distant metastases (i.e. non regional lymph nodes)
  • Peritoneal carcinomatosis

References

  1. Pancreatic Cancer - Johns Hopkins Medicine: Surgical Treatment of Pancreatic Cancer
  2. Retrieved from http://pathology.jhu.edu/pancreas/TreatmentSurgery.php.
  3. Neoptolemos JP, Stocken DD, Friess H; et al. (2004). "A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer". N. Engl. J. Med. 350 (12): 1200–10. doi:10.1056/NEJMoa032295. PMID 15028824.


Template:WikiDoc Sources